eISSN: 2299-0046
ISSN: 1642-395X
Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii
Current issue Archive Manuscripts accepted About the journal Abstracting and indexing Subscription Contact Instructions for authors
SCImago Journal & Country Rank
vol. 35
Review paper

Obesity and asthma: risk, control and treatment

Monika Marko, Rafał Pawliczak

Adv Dermatol Allergol 2018; XXXV (6): 563-571
Online publish date: 2018/08/13
View full text
Get citation
JabRef, Mendeley
Papers, Reference Manager, RefWorks, Zotero
Asthma and obesity are currently one of the most common diseases. Observing an increase in morbidity of obesity and asthma, it can be concluded that there is a link between these diseases. But the mechanism of this relation is not well known. Due to reduced movement in patients and treatment, asthma is conducive to obesity, and obesity can exacerbate the symptoms associated with asthma. Obesity can affect bronchial hyperresponsiveness. Increasing body fat in obese people leads to systemic inflammation and elevated serum levels of many proinflammatory cytokines (e.g. leptin) and anti-inflammatory ones (e.g. adiponectin) that can have a causal relationship to bronchial asthma, but human studies are ambiguous. Obese asthmatics are characterized by a phenotype: heavier asthma, worse response to treatment and control of asthma. It has been found that in obese people, weight loss reduces the severity of asthma symptoms, so in these patients, treatment should include weight control.

body mass index, obesity, asthma, control, treatment

Gomez-Llorente A, Romero R, Chueca N, et al. Obesity and asthma: a missing link. Int J Mol Sci 2017; 18: 1490.
Machluf Y, Farkash R, Fink D, et al. Asthma severity and heterogeneity: insights from prevalence trends and associated demographic variables and anthropometric indices among Israeli adolescents. J Asthma 2017; 1532: 4303.
Forno E, Celedon JC. The effect of obesity, weight gain, and weight loss on asthma inception and control. Curr Opin Allergy Clin Immunol 2017; 17: 123-30.
Scott AH, Wood LG, Gibson P. Role of obesity in asthma: mechanisms and management strategies. Curr Allergy Asthma Rep 2017; 17: 53.
Rajappan A, Pearce A, Inskip H, et al. Maternal body mass index: relation with infant respiratory symptoms and infections. Pediatr Pulmonol 2017; 52: 1291-9.
Forno E, Young OM, Kumar R, et al. Maternal obesity in pregnancy, gestational weight gain, and risk of childhood asthma. Pediatrics 2014; 134: e535-46.
den Dekker HT, Ros KPI, de Jongste JC, et al. Body fat mass distribution and interrupter resistance, fractional exhaled nitric oxide, and asthma at school-age. J Allergy Clin Immunol 2017; 139: 810-8.
Dumas O, Varraso R, Gillman MW, et al. Longitudinal study of maternal body mass index, gestational weight gain, and offspring asthma. Allergy 2016; 71: 1295-304.
Chih AH, Chen YC, Tu YK, et al. Mediating pathways from central obesity to childhood asthma: a population-based longitudinal study. Eur Respir J 2016; 48: 748-57.
Strunk RC, Colvin R, Bahcarier LB, et al. Airway obstruction worsens in young adults with asthma who become obese. J Allergy Clin Immunol Pract 2015; 3: 765-71.
Okubo Y, Nochioka K, Hataya H, et al. Burden of obesity on pediatric inpatients with acute asthma exacerbation in the United States. J Allergy Clin Immunol Pract 2016; 4: 1227-31.
Myung J, Lee H, Kim TH, et al. Relationships between self-reported asthma and pulmonary function and various measures of obesity. J Asthma 2018; 55: 741-9.
Maniscalco M, Paris D, Melck DJ, et al. Coexistence of obesity and asthma determines a distinct respiratory metabolic phenotype. J Allergy Clin Immunol 2017; 139: 1536-47.e5.
Forno E. Asthma and obesity: the chicken, the egg, or more than one beast? Am J Respir Crit Care Med 2017; 195: 1124-5.
Nacaroglu HT, Gayret OB, Erol M, et al. Biomarkers of airway and systemic inflammation in obese asthmatic paediatric patients. Allergol Immunopathol (Madr) 2017; 45: 534-40.
Newson RB, Jones M, Forsberg B, et al. The association of asthma, nasal allergies, and positive skin prick test with obesity, leptin, and adiponectin. Clin Exp Allergy 2013; 44: 250-60.
Jeong KY, Lee J, Li C. Juvenile obesity aggravates disease severity in a rat model of atopic dermatitis. Allergy Asthma Immunol Res 2015; 7: 69-75.
Rastogi D, Fraser S, Oh J, et al. Inflammation, metabolic dysregulation, and pulmonary function among obese urban adolescents with asthma. Am J Respir Crit Care Med 2015; 191: 149-60.
Toru U, Ayada C, Genç O, et al. Visfatin and ghrelin: can they be forthcoming biomarkers or new drug targets for asthma? Int J Clin Exp Med 2015; 8: 6257-61.
Dixit VD, Taub DD. Ghrelin and immunity: a young player in an old field. Exp Gerontol 2005; 40: 900-10.
Yuksel H, Sogut A, Yilmaz O, et al. Role of adipokines and hormones of obesity in childhood asthma. Allergy Asthma Immunol Res 2012; 4: 98-103.
Tsaroucha A, Daniil Z, Malli F, et al. Leptin, adiponectin, and ghrelin levels in female patients with asthma during stable and exacerbation periods. J Asthma 2013; 50: 188-97.
Forno E, Acosta-Pérez E, Brehm JM, et al. Obesity and adiposity indicators, asthma, and atopy in Puerto Rican children. J Allergy Clin Immunol 2014; 133: 1308-14.
Sannette C, Hall BS, Devendra K. Vitamin D and bronchial asthma: an overview of data from the past 5 years. Clin Therap 2017; 39: 917-29.
Umetsu DT. Mechanisms by which obesity impacts upon asthma. Thorax 2017; 72: 174-7.
Varricchi G, Bagnasco D, Borriello. Interleukin-5 pathway inhibition in the treatment of eosinophilic respiratory disorders: evidence and unmet needs. Curr Opin Allergy Clin Immunol 2016; 16: 186-200.
Ortega HG, Liu MC, Pavord ID, et al. Mepolizumab treatment in patients with severe eosinophilic asthma. N Engl J Med 2014; 371: 1198-207.
Ortega H, Li H, Suruki R, et al. Cluster analysis and characterization of response to mepolizumab. A step closer to personalized medicine for patients with severe asthma. Ann Am Thorac Soc 2014; 11: 1011-7.
Shore SA, Cho Y. Obesity and asthma: microbiome-metabolome interactions. Am J Respir Cell Mol Biol 2016; 54: 609-17.
Yadav H, Lee JH, Lloyd J, et al. Beneficial metabolic effects of probiotics via butyrate-induced GLP-1 hormone secretion. J Biol Chem 2013; 288: 25088-97.
Miyoshi M, Ogawa A, Higurashi S, et al. Anti-obesity effect of Lactobacillus gasseri SBT2055 accompanied by inhibition of pro-inflammatory gene expression in the visceral adipose tissue in diet-induced obese mice. Eur J Nutr 2014; 53: 599-606.
Zarrati M, Salehi E, Mofid V, et al. Relationship between probiotic consumption and IL-10 and IL-17 secreted by PBMCs in overweight and obese people. Iran J Allergy Asthma Immunol 2013; 12: 404-6.
Minami J, Kondo S, Yanagisawa N, et al. Oral administration of Bifidobacterium breve B-3 modifies metabolic functions in adults with obese tendencies in a randomised controlled trial. J Nutr Sci 2015; 4: e17.
Ridaura VK, Faith JJ, Rey FE, et al. Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science 2013; 341: 12412-4.
Sharafedtinov KK, Plotnikova OA, Alexeeva RI, et al. Hypocaloric diet supplemented with probiotic cheese improves body mass index and blood pressure indices of obese hypertensive patients – a randomized double-blind placebo-controlled pilot study. Nutr J 2013; 12: 138.
Salazar N, Dewulf EM, Neyrinck AM, et al. Inulin-type fructans modulate intestinal Bifidobacterium species populations and decrease fecal short-chain fatty acids in obese women. Clin Nutr 2015; 34: 501-7.
Safavi M, Farajian S, Kelishadi R, et al. The effects of symbiotic supplementation on some cardio-metabolic risk factors in overweight and obese children. A randomized triple-masked controlled trial. Int J Food Sci Nutr 2013; 64: 687-93.
Dzidic M, Abrahamsson TR, Artacho A, et al. Aberrant IgA responses to the gut microbiota during infancy precede asthma and allergy development. J Allergy Clin Immunol 2016; 139: 1017-25.
Shore SA, Cho Y. Obesity and asthma: microbiome-metabolome interactions. Am J Respir Cell Mol Biol 2016; 54: 609-17.
Murphy R, Stewart AW, Braithwaite I, et al.; ISAAC Phase Three Study Group. Antibotic treatment during infancy and increased body mass index in boys: an international cross-sectional study. Int J Obes 2014; 38: 1115-9.
Korpela K, Salonen A, Virta LJ, et al. Intestinal microbiome is related to lifetime antibiotic use in Finnish pre-school children. Nat Commun 2015; 7: 10410-8.
Dzidic M, Abrahamsson TR, Artacho A, et al. Aberrant IgA response to the gut microbiota during infancy precede asthma and allergy development. J Allergy Clin Immunol 2017; 139: 1017-25.
Orivouri L, Mustonen K, Goffau MC, et al. High level of fecal calpropectin at age 2 months as a marker of intestinal inflammation predicts atopic dermatitis and asthma by age 6. Clin Exp Allergy 2015; 45: 928-39.
Trompette A, Gollwitzer ES, Yadava K, et al. Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis. Nat Med 2014; 20: 159-68.
Vatanen T, Kostic AD, D’Hennezel E, et al. Variation in microbiome LPS immunogenicity contributes to autoimmunity in humans. Cell 2016; 165: 842-53.
Jensen ME, Gibson PG, Collins CE, et al. Diet-induced weight loss in obese children with asthma: a randomized controlled trial. Clin Exp Allergy 2013; 43: 775-84.
van Leeuwen JC, Hoogstrate M, Duiverman EJ, et al. Effects of dietary induced weight loss on exercise-induced bronchoconstriction in overweight and obese children. Pediatr Pulmonol 2014; 49: 1155-61.
Willeboordse M, Kant KD, Tan FE, et al. A multifactorial weight reduction programme for children with overweight and asthma: a randomized controlled trial. PLoS One 2016; 11: e0157158.
Luna-Pech JA, Torres-Mendoza BM, Luna-Pech JA, et al. Normocaloric diet improves asthma-related quality of life in obese pubertal adolescents. Int Arch Allergy Immunol 2014; 163: 252-8.
Li CY, Erickson SR, Wu CH. Metformin use and asthma outcomes among patients with concurrent asthma and diabetes. Respirology 2016; 21: 1210-8.
Quick links
© 2019 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe